Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.570
0.00 (0.00%)
At close: Jan 23, 2026
Nuo Therapeutics Revenue
Nuo Therapeutics had revenue of $1.03M in the quarter ending September 30, 2025, with 178.23% growth. This brings the company's revenue in the last twelve months to $2.61M, up 123.72% year-over-year. In the year 2024, Nuo Therapeutics had annual revenue of $1.37M with 124.34% growth.
Revenue (ttm)
2.61M
Revenue Growth
+123.72%
P/S Ratio
29.03
Revenue / Employee
290.17K
Employees
9
Market Cap
75.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.37M | 756.65K | 124.34% |
| Dec 31, 2023 | 608.53K | 496.28K | 442.12% |
| Dec 31, 2022 | 112.25K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioStem Technologies | 292.21M |
| Vaxart | 148.20M |
| LakeShore Biopharma | 84.75M |
| Harvard Apparatus Regenerative Technology | 743.00K |
| ZIVO Bioscience | 209.03K |
| Ayala Pharmaceuticals | 13.00K |
| Arch Biopartners | -62.11K |
Nuo Therapeutics News
- 5 weeks ago - Nuo Therapeutics (AURX) Sees Positive Coverage Initiation by Roth Capital | AURX Stock News - GuruFocus
- 9 months ago - Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew - GlobeNewsWire
- 10 months ago - Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies - GlobeNewsWire
- 2 years ago - Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange - GlobeNewsWire
- 2 years ago - Nuo Therapeutics' Aurix® System Added To Wound Care Formulary Of Wound Care Advantage - GlobeNewsWire
- 3 years ago - Nuo Therapeutics Provides Corporate and Business Update - GlobeNewsWire